📰 Merck Sharp News
Page 7 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
March 28, 2024
Even if patients with EGFR-mutated lung cancer progress on amivantamab plus chemotherapy, there is a survival benefit over chemotherapy alone, follow-up analyses of PAPILLON and MARIPOSA-2 showed.
March 26, 2024
NGM Biopharmaceuticals (NASDAQ:NGM – Get Free Report) and AgeX Therapeutics (NYSE:AGE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Volatility and Risk NGM Biopharmaceuticals has a […]
March 26, 2024
In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024.
March 26, 2024
Pembrolizumab in combination with chemotherapy followed by maintenance olaparib did not meet its pre-specified statistical criteria of overall survival or progression free survival.
March 23, 2024
NGM Biopharmaceuticals (NASDAQ:NGM – Get Free Report) and AgeX Therapeutics (NYSE:AGE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Volatility & Risk NGM Biopharmaceuticals has a […]
March 13, 2024
Last week, the Federal Circuit handed down its opinion in Pfizer Inc. v. Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S....
March 12, 2024
Trial will evaluate IDE161, IDEAYAs investigational PARG inhibitor, in combination with KEYTRUDA® , Mercks anti-PD-1 therapy, in patients with MSI-high and MSS endometrial cancer Potential...
February 28, 2024
Perhaps one of your patients would benefit from enrolling in a new clinical trial in leukemia or lymphoma?
February 22, 2024
When thinking about his legacy as a Montgomery County Commissioner, Ken Lawrence Jr. took inspiration from Broadway, quoting a line from Hamilton.
February 22, 2024
Posts fourth quarter revenues of $2.8 billion, GAAP net income of $217 million and GAAP diluted EPS of $0.55Reports full-year revenues of $6.8 billion, GAAP net loss of $(4.7) billion and GAAP diluted EPS of $(12.33); loss primarily driven by mostly non-cash charges of $3.7 billion related to resizing and a tax valu...